BRIEF-Merck Gets Positive EU Opinion to Expand ENFLONSIA Use for Young Children

Nov 13 (Reuters) – Merck & Co Inc: * MERCK RECEIVES POSITIVE EU CHMP OPINION TO EXPAND MARKETING AUTHORIZATION FOR ENFLONSIA® (CLESROVIMAB) TO INCLUDE CHILDREN UP TO 24 MONTHS OF AGE WHO REMAIN

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)